Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fowler

Showing results (891-900 of 957) with videos related to

Pageof 96
Sort By:
American Journal of Human Genetics|December 6, 2024
A missense variant effect map for the human tumor-suppressor protein CHK2Marinella Gebbia, Daniel Zimmerman, Rosanna Jiang, et al.
The Science of the Total Environment|April 18, 2018
Eyes in the sea: Unlocking the mysteries of the ocean using industrial, remotely operated vehicles (ROVs)Peter I Macreadie, Dianne L McLean, Paul G Thomson, et al.
Gynecologic Oncology|August 31, 2016
Stress and burnout among gynecologic oncologists: A Society of Gynecologic Oncology Evidence-based Review and RecommendationsIlana Cass, Linda R Duska, Stephanie V Blank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumorsPravin T P Kaumaya, Kevin Chu Foy, Joan Garrett, et al.
Gynecologic Oncology|July 16, 2017
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survivalCasey M Cosgrove, David E Cohn, Heather Hampel, et al.
Gynecologic Oncology|December 14, 2021
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology studyUrsula A Matulonis, Helen Q Huang, Virginia L Filiaci, et al.
Science Translational Medicine|March 24, 2012
Characterization of circulating endothelial cells in acute myocardial infarctionSamir Damani, Andrea Bacconi, Ondrej Libiger, et al.
Physical Review Letters|December 11, 2012
New precision measurements of the 235U(n,γ) cross sectionM Jandel, T A Bredeweg, E M Bond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer IntergroupMichael A Bookman, Mark F Brady, William P McGuire, et al.
Gynecologic Oncology|November 28, 2017
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 StudyNeil S Horowitz, G Larry Maxwell, Austin Miller, et al.
Pageof 96

Showing results (891-900 of 957) with videos related to

Sort By:
Pageof 96
American Journal of Human Genetics|December 6, 2024
A missense variant effect map for the human tumor-suppressor protein CHK2Marinella Gebbia, Daniel Zimmerman, Rosanna Jiang, et al.
The Science of the Total Environment|April 18, 2018
Eyes in the sea: Unlocking the mysteries of the ocean using industrial, remotely operated vehicles (ROVs)Peter I Macreadie, Dianne L McLean, Paul G Thomson, et al.
Gynecologic Oncology|August 31, 2016
Stress and burnout among gynecologic oncologists: A Society of Gynecologic Oncology Evidence-based Review and RecommendationsIlana Cass, Linda R Duska, Stephanie V Blank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumorsPravin T P Kaumaya, Kevin Chu Foy, Joan Garrett, et al.
Gynecologic Oncology|July 16, 2017
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survivalCasey M Cosgrove, David E Cohn, Heather Hampel, et al.
Gynecologic Oncology|December 14, 2021
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology studyUrsula A Matulonis, Helen Q Huang, Virginia L Filiaci, et al.
Science Translational Medicine|March 24, 2012
Characterization of circulating endothelial cells in acute myocardial infarctionSamir Damani, Andrea Bacconi, Ondrej Libiger, et al.
Physical Review Letters|December 11, 2012
New precision measurements of the 235U(n,γ) cross sectionM Jandel, T A Bredeweg, E M Bond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer IntergroupMichael A Bookman, Mark F Brady, William P McGuire, et al.
Gynecologic Oncology|November 28, 2017
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 StudyNeil S Horowitz, G Larry Maxwell, Austin Miller, et al.
Pageof 96